Glazer calls 'invisible radiologist' to task, encourages molecular understanding
A smorgasbord of challenges face radiology but few present a greater threat than the “invisible radiologist,” said Dr. Gary Glazer, chairman of the Stanford University radiology department, who kicked off the 11th International Symposium on Multidetector-Row CT.
A smorgasbord of challenges face radiology but few present a greater threat than the “invisible radiologist,” said Dr. Gary Glazer, chairman of the Stanford University radiology department, who kicked off the 11th International Symposium on Multidetector-Row CT.
Glazer flashed a four-year-old New York Times story on the screen, an anecdote of a woman who waited weeks to learn the results of a CT scan. The suspicious lesion was noncancerous, but the experience was a nightmare. The story crystallized concerns by Glazer about the invisibility of the radiologist.
“It is quite clear, in a high percentage, as high as 90%, that the patient never speaks with the physician interpreting the scan,” Glazer said. “There has been a huge amount of work undertaken over the last decade at improving efficiency of workflow and developing ideal workstations – but these sorts of questions have all related to the life of the radiologist. The patient has been nowhere in this consideration.”
This must change in the years to come, he said. “If healthcare is to improve, the interaction of radiologist and patients must be optimized,” Glazer said.
Among the other challenges and, by extension, opportunities for radiology is for CT to push the boundaries of biology not so much for diagnostic as therapeutic purposes. Glazer said CT has a role to play in personalized medicine, particularly in helping physicians tailor drug therapy to improve outcomes and reduce costs by focusing on those that are effective. This will be done by moving backwards from the image to the molecular underpinnings of disease by correlating what is seen in radiology to genomics, he said.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
